Dr. Hiranya Attana Rajasinghe, MD

Dr. Rajasinghe practices at The Vascular Group of Naples in Naples, Florida.

Dr. Rajasinghe's NPI, 1720186430, was assigned on September 20, 2006. Dr. Rajasinghe graduated from Duke University School Of Medicine in 1992. Dr. Rajasinghe holds Florida license ME86677.

Dr. Rajasinghe's primary practice is The Vascular Group of Naples, at 2450 Goodlette Rd N Ste 102, Naples, FL 34103-4595. The practice phone is (239) 643-8794.

Dr. Rajasinghe's primary practice is The Vascular Group of Naples in Naples, Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajasinghe practices. Vendor and product names are available with a free account.

Vascular surgery is Dr. Rajasinghe's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Rajasinghe is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Rajasinghe's licenses on file in 4 states: Florida, California, Ohio and New York.

Dmand AI lists amputation, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and lymphedema among the conditions Dr. Rajasinghe treats.

CMS data shows 3,322 Medicare services from Dr. Rajasinghe across 24 procedure codes in 2024, for 304 Medicare patients. Medicare paid $460,655 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Rajasinghe in 2024. The largest group is 75 to 84, with 159 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rajasinghe's median patient age at 79, with 40% women.

In 2024, Dr. Rajasinghe wrote 173 Medicare Part D claims for 50 patients. 82% of them were for generic drugs. CMS names the drug for 156 of them, across 3 drugs with 11 or more claims each, at $28,519 in total drug cost. In 2023, CMS named 173 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Rajasinghe for performance year 2024, reported individually. Dr. Rajasinghe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rajasinghe as offering telehealth. CMS counts 11 procedures of leg revascularization (restoring blood flow) by Dr. Rajasinghe, more than 64% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Rajasinghe, published from 2012 to 2019. The most frequent topics are Postoperative Complications, Heart Transplantation and Reoperation. Dr. Rajasinghe has published most often in Ann Thorac Surg. Dr. Rajasinghe's most frequent co-authors are Frank Louis Hanley, MD, Doff Bryan McElhinney, MD and Niloo M. Edwards, MD.

CMS Open Payments shows 902 general payments to Dr. Rajasinghe from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. W. L. Gore & Associates, Inc. paid the most, $22,097.

Dmand AI lists 10 awards for Dr. Rajasinghe, most recently Top Doctors in 2020.

Dr. Rajasinghe graduated from Duke University School Of Medicine in 1992. Dr. Rajasinghe is a member of ACS.

Dr. Rajasinghe is in network with 19 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.